跳至主要内容
临床试验/IRCT20200823048482N1
IRCT20200823048482N1招募中3 期

The Effect of Taladafil on Improvement of Lung Function and Asthma Attacks in Patients with Severe Asthma

Ahvaz University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • The Patients with Severe Asthma

排除标准

  • Mild to moderate severity
  • Using Immunosuppressive Drug and Corticosteroid ( Greater than 5 mg Dose) Outside the Study Protocol in Three Months Ago
  • Advanced Liver Failure (Liver Cirrhosis), Advanced Renal Failure (CKD Stage 4,5)
  • Uncontrolled Hypertension
  • Havingany Untreated Disease such as Reflux, Sinusitis or Allergic Bronchopulmonary Aspergillosis (ABPA) based on History and Paraclinical Tests which Trigger Asthma Exacerbation Continuously
  • Prohibition of Phosphodiesterase Inhibitors and Nitrate Consumption

研究者

相似试验